Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danning Tablet for Multiple Gallbladder Polyps
NCT05668871Phase 4Completed
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Dec 2022
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Danning Tablet in gallbladder polyp (2 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoint: Clinical Efficacy Rate at 24 weeks. Started Dec 2022; status: completed.
02
Drugs
Danning Tablet
03
Conditions
gallbladder polyp
Beyond the preview
Go deeper on NCT05668871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05668871.